title: [Inhibition of soy isoflavone intake on bone loss in menopausal women: evaluated by meta-analysis of randomized controlled trials].
abstract: OBJECTIVE
  To clarify the effects of soy isoflavone intake on bone loss, meta-analysis of randomized controlled trials (RCTs) was performed.
  
  
  METHODS
  RCTs that observed the effects of soy isoflavone intake on urinary deoxypyridinoline (Dpyr), serum bone-specific alkaline phosphatase (BAP), and spine bone mineral density (SBMD) were searched by MEDLINE, CNKI, and so on. Meta-analysis for the RCTs selected in the analysis was performed.
  
  
  RESULTS
  Eighteen studies with a total of 978 subjects were selected for the analysis. The urinary Dpyr concentration in subjects who consumed isoflavones significantly decreased by - 2.08 nmol/mmol (95% CI: -3.82 - 0.34) in comparison to that in subjects who did not consume isoflavones. However, isoflavone intake significantly increased serum BAP by 1.48 microg/L (95% CI: 0.22 - 2.75). The SBMD in subjects who consumed isoflavones increased significantly by 20.6 mg/cm2 (95% CI: 4.5 - 36.6). Subjects who consumed isoflavone more than 90 mg/day and or 6 months increased SBMD as 28.5 mg/cm2 (95% CI: 8.4 - 48.6) and 27 mg/cm2 (95% CI: 8.3 - 45.8), respectively.
  
  
  CONCLUSIONS
  It was suggested that the bone loss in menopausal women attenuated by isoflavone intervention could be associated with inhibition of bone resorption and stimulation of bone formation.
authors.affiliation: Department of Social Medicine & Health Education, School of Public Health, Peking University, Beijing 100191, China. defuma2008@hotmail.com
authors.forename: Defu
authors.initials: D
authors.lastname: Ma
authors.forename: Liqiang
authors.initials: L
authors.lastname: Qin
authors.forename: Baohua
authors.initials: B
authors.lastname: Liu
authors.forename: Peiyu
authors.initials: P
authors.lastname: Wang
mesh_terms: D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000652:urine; D015519:Bone Density / Q000187:drug effects; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000008:administration & dosage*; D008593:Menopause; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D013025:Glycine max / Q000737:chemistry*
chemical_list: D000596:Amino Acids; D007529:Isoflavones; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase